Roschier acts as legal advisor to Navamedic in the recommended cash offer to acquire Sensidose
Nordic pharma company Navamedic ASA has submitted a cash offer to acquire all shares in the Swedish pharmaceutical company Sensidose AB for approximately SEK 75 million. Roschier represents Navamedic in the offer.
The offer submitted by Navamedic is recommended by the board of directors of Sensidose.
Navamedic ASA is a provider of high-quality products to hospitals and pharmacies. Sensidose AB has developed a system for individualized dosing of tablets. Its shares are currently listed on Spotlight Stock Market in Sweden.
Roschier’s main advisory team comprises Christoffer Benninge, Erik Ficks, Kristian Hugmark, Niklas Eriksson, Richard Katzman, Jacob Giesecke, Pontus Berganäs and Louise Björnsson.